ACS Infectious Diseases · 2019 · 26 citations · 16 references
Life SciencesBiochemistryPharmacologyEnzymologyLipid BiochemistryStructure-activity RelationshipsEnzyme DiscoveryEnzyme InhibitionStructure-activity Relationship AnalysisAntibiotic DiscoveryAntibiotic Target AlterationBiochemical CharacterizationEnzymatic InhibitionEnzyme Inhibition ScreeningInhibitor ScreeningNovel Antibacterial AgentsPhosphatase Inhibition
The UDP-2,3-diacylglucosamine pyrophosphatase LpxH in the Raetz pathway of lipid A biosynthesis is an essential enzyme in the vast majority of Gram-negative pathogens and an excellent novel antibiotic target. The 32P-radioautographic thin-layer chromatography assay has been widely used for analysis of LpxH activity, but it is inconvenient for evaluation of a large number of LpxH inhibitors over an extended time period. Here, we report a coupled, nonradioactive LpxH assay that utilizes the recently discovered Aquifex aeolicus lipid A 1-phosphatase LpxE for quantitative removal of the 1-phosphate from lipid X, the product of the LpxH catalysis; the released inorganic phosphate is subsequently quantified by the colorimetric malachite green assay, allowing the monitoring of the LpxH catalysis. Using such a coupled enzymatic assay, we report the biochemical characterization of a series of sulfonyl piperazine LpxH inhibitors. Our analysis establishes a preliminary structure–activity relationship for this class of compounds and reveals a pharmacophore of two aromatic rings, two hydrophobic groups, and one hydrogen-bond acceptor. We expect that our findings will facilitate the development of more effective LpxH inhibitors as potential antibacterial agents.
16
Antibacterial Agents That Inhibit Lipid A Biosynthesis
Hiroshi Ōnishi, Barbara A. Pelak, Lynn S. Gerckens et al. · Science · 1996 · 410 citations